Search
Sign In
Sign In
Sources
5 Total Sources
Novartis Shares Jump 4% After MS Drug Remibrutinib Cuts Relapse Rates
Left
50%
Center
50%
All
5
Left
2
Center
2
Others
1
CNBC
2h ago
Novartis Shares Rise 4% on Positive Remibrutinib Multiple Sclerosis Drug Trial Data
MedWatch
1h ago
Novartis reports positive phase 3 results for multiple sclerosis drug candidate
m.investing.com
2h ago
Novartis shares rise after multiple sclerosis drug hits late-stage trial goals By Investing.com
Yahoo! Voices
4h ago
Novartis pauses trials of experimental cell therapy after three deaths
Yahoo News Canada
4h ago
Novartis pauses trials of experimental cell therapy after three deaths - Yahoo News Canada